PainReform Ltd. Files April 2025 Report on Form 6-K
Ticker: PRFX · Form: 6-K · Filed: Apr 11, 2025 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
PainReform filed its April 6-K, incorporating into existing S-8 and F-3 filings. Standard update.
AI Summary
PainReform Ltd. filed a Form 6-K on April 11, 2025, to report its activities for the month of April 2025. This report is incorporated by reference into several of the company's existing registration statements on Form S-8 and Form F-3. The company's principal executive offices are located at 65 Yigal Alon St., Tel Aviv, Israel.
Why It Matters
This filing provides an update on PainReform Ltd.'s ongoing reporting obligations and incorporates information into its existing SEC registration statements, which is crucial for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain new material financial or operational information that would typically increase risk.
Key Players & Entities
- PainReform Ltd. (company) — Registrant
- 001-39481 (company) — Commission File Number
- 65 Yigal Alon St., Tel Aviv 6744316 Israel (company) — Principal executive offices
- Form S-8 (company) — Registration Statement Type
- Form F-3 (company) — Registration Statement Type
- November 4, 2024 (date) — Letter date
- April 2025 (date) — Reporting period
- April 11, 2025 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Section 13A-16 or 15D-16 under the Securities Exchange Act of 1934, for the month of April 2025.
Which registration statements does this 6-K filing get incorporated into?
This report is incorporated by reference into the Company's Registration Statements on Form S-8 (Registration No. 333-257968 and 333-265902) and Form F-3 (Registration No. 333-282264, 333-254982, 333-276485 and 333-277594).
What is the company's principal executive office address?
The company's principal executive offices are located at 65 Yigal Alon St., Tel Aviv 6744316 Israel.
Does PainReform Ltd. file annual reports under Form 20-F or Form 40-F?
PainReform Ltd. indicates it files annual reports under cover of Form 20-F.
What is the Commission File Number for PainReform Ltd.?
The Commission File Number for PainReform Ltd. is 001-39481.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 11, 2025 regarding PAINREFORM LTD. (PRFX).